3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Melanoma
15
Neoplasm Metastasis
11
Ovarian Neoplasms
9
Pancreatic Neoplasms
8
Carcinoma, Non-Small-Cell Lung
8
Stomach Neoplasms
6
Skin Neoplasms
6
Leukemia, Myeloid, Acute
6
Colorectal Neoplasms
6
Carcinoma, Renal Cell
6
Triple Negative Breast Neoplasms
4
Gastrointestinal Neoplasms
4
Breast Neoplasms
4
Vulvar Neoplasms
3
Uterine Cervical Neoplasms
3
Urogenital Neoplasms
3
Rectal Neoplasms
3
Neuroblastoma
3
Myelodysplastic Syndromes
3
Multiple Myeloma
3
Leukemia
3
Colonic Neoplasms
3
Vaginal Neoplasms
2
Squamous Cell Carcinoma of Head and Neck
2
Sarcoma
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Pleural Effusion, Malignant
2
Penile Neoplasms
2
Oropharyngeal Neoplasms
2
Neoplasms
2
Interventions
Rituximab
45
Cyclophosphamide
32
Lenalidomide
24
fludarabine
20
zanubrutinib
13
venetoclax
12
obinutuzumab
12
orelabrutinib
11
fludarabine phosphate
10
Bendamustine Hydrochloride
10
Magnetic Resonance Spectroscopy
9
Whole-Body Irradiation
8
Prednisone
8
pirtobrutinib
7
ibrutinib
7
Vincristine
7
Specimen Handling
7
CT-P10
7
Mycophenolic Acid
6
Biopsy
6
Doxorubicin
5
tafasitamab
4
pembrolizumab
3
acalabrutinib
3
Tacrolimus
3
Sirolimus
3
Radiotherapy
3
Peripheral Blood Stem Cell Transplantation
3
Nivolumab
3
Melphalan
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Lymphoma, B-Cell, Marginal Zone
×
aldesleukin
×
1 year
×
Clear all
No trials found.